{"id":8183,"date":"2025-06-03T23:34:13","date_gmt":"2025-06-04T04:34:13","guid":{"rendered":"https:\/\/www.rxbriefcase.com\/product\/implementing-nk3-antagonists-in-clinical-practice\/?courseid="},"modified":"2026-04-13T12:47:16","modified_gmt":"2026-04-13T17:47:16","slug":"implementing-nk3-antagonists-in-clinical-practice","status":"publish","type":"product","link":"https:\/\/www.rxbriefcase.com\/fr\/product\/implementing-nk3-antagonists-in-clinical-practice\/?courseid=","title":{"rendered":"Implementing NK3 Antagonists in Clinical Practice"},"content":{"rendered":"<p dir=\"ltr\" style=\"text-align: left\">NK3 antagonists represent a novel treatment option for the management of vasomotor symptoms (VMS) associated with menopause. This program will review practical considerations for prescribing this new class of medications, including dosage, side effects, and monitoring requirements. By the end of the session, clinicians will be better equipped with the knowledge and confidence to integrate this treatment into practice when appropriate, using effective clinical decision-making.\n<\/p>\n<hr>\n<p dir=\"ltr\" style=\"text-align: left\">This program has received an unrestricted educational grant or in-kind support from Astellas Pharma Canada Inc.<\/p>","protected":false},"excerpt":{"rendered":"<p>NK3 antagonists represent a novel treatment option for the management of vasomotor symptoms (VMS) associated with menopause. This program will review practical considerations for prescribing this new class of medications, including dosage, side effects, and monitoring requirements. By the end of the session, clinicians will be better equipped with the knowledge and confidence to integrate [&hellip;]<\/p>\n","protected":false},"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false},"product_brand":[],"product_cat":[],"product_tag":[],"class_list":{"0":"post-8183","1":"product","2":"type-product","3":"status-publish","6":"first","7":"instock","8":"downloadable","9":"virtual","10":"taxable","11":"purchasable","12":"product-type-simple"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Implementing NK3 Antagonists in Clinical Practice - RxBriefCase<\/title>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Implementing NK3 Antagonists in Clinical Practice - RxBriefCase\" \/>\n<meta property=\"og:description\" content=\"NK3 antagonists represent a novel treatment option for the management of vasomotor symptoms (VMS) associated with menopause. This program will review practical considerations for prescribing this new class of medications, including dosage, side effects, and monitoring requirements. By the end of the session, clinicians will be better equipped with the knowledge and confidence to integrate [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rxbriefcase.com\/fr\/product\/implementing-nk3-antagonists-in-clinical-practice\/?courseid=\" \/>\n<meta property=\"og:site_name\" content=\"RxBriefCase\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-13T17:47:16+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.rxbriefcase.com\/product\/implementing-nk3-antagonists-in-clinical-practice\/?courseid=\",\"url\":\"https:\/\/www.rxbriefcase.com\/product\/implementing-nk3-antagonists-in-clinical-practice\/?courseid=\",\"name\":\"Implementing NK3 Antagonists in Clinical Practice - RxBriefCase\",\"isPartOf\":{\"@id\":\"https:\/\/www.rxbriefcase.com\/#website\"},\"datePublished\":\"2025-06-04T04:34:13+00:00\",\"dateModified\":\"2026-04-13T17:47:16+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.rxbriefcase.com\/product\/implementing-nk3-antagonists-in-clinical-practice\/?courseid=#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.rxbriefcase.com\/product\/implementing-nk3-antagonists-in-clinical-practice\/?courseid=\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.rxbriefcase.com\/product\/implementing-nk3-antagonists-in-clinical-practice\/?courseid=#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.rxbriefcase.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shop\",\"item\":\"https:\/\/www.rxbriefcase.com\/shop\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Implementing NK3 Antagonists in Clinical Practice\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.rxbriefcase.com\/#website\",\"url\":\"https:\/\/www.rxbriefcase.com\/\",\"name\":\"RxBriefCase\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.rxbriefcase.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.rxbriefcase.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.rxbriefcase.com\/#organization\",\"name\":\"RxBriefCase\",\"url\":\"https:\/\/www.rxbriefcase.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.rxbriefcase.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.rxbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp\",\"contentUrl\":\"https:\/\/www.rxbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp\",\"width\":190,\"height\":36,\"caption\":\"RxBriefCase\"},\"image\":{\"@id\":\"https:\/\/www.rxbriefcase.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Implementing NK3 Antagonists in Clinical Practice - RxBriefCase","robots":{"index":"noindex","follow":"follow"},"og_locale":"fr_CA","og_type":"article","og_title":"Implementing NK3 Antagonists in Clinical Practice - RxBriefCase","og_description":"NK3 antagonists represent a novel treatment option for the management of vasomotor symptoms (VMS) associated with menopause. This program will review practical considerations for prescribing this new class of medications, including dosage, side effects, and monitoring requirements. By the end of the session, clinicians will be better equipped with the knowledge and confidence to integrate [&hellip;]","og_url":"https:\/\/www.rxbriefcase.com\/fr\/product\/implementing-nk3-antagonists-in-clinical-practice\/?courseid=","og_site_name":"RxBriefCase","article_modified_time":"2026-04-13T17:47:16+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.rxbriefcase.com\/product\/implementing-nk3-antagonists-in-clinical-practice\/?courseid=","url":"https:\/\/www.rxbriefcase.com\/product\/implementing-nk3-antagonists-in-clinical-practice\/?courseid=","name":"Implementing NK3 Antagonists in Clinical Practice - RxBriefCase","isPartOf":{"@id":"https:\/\/www.rxbriefcase.com\/#website"},"datePublished":"2025-06-04T04:34:13+00:00","dateModified":"2026-04-13T17:47:16+00:00","breadcrumb":{"@id":"https:\/\/www.rxbriefcase.com\/product\/implementing-nk3-antagonists-in-clinical-practice\/?courseid=#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rxbriefcase.com\/product\/implementing-nk3-antagonists-in-clinical-practice\/?courseid="]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.rxbriefcase.com\/product\/implementing-nk3-antagonists-in-clinical-practice\/?courseid=#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rxbriefcase.com\/"},{"@type":"ListItem","position":2,"name":"Shop","item":"https:\/\/www.rxbriefcase.com\/shop\/"},{"@type":"ListItem","position":3,"name":"Implementing NK3 Antagonists in Clinical Practice"}]},{"@type":"WebSite","@id":"https:\/\/www.rxbriefcase.com\/#website","url":"https:\/\/www.rxbriefcase.com\/","name":"Mallette Rx","description":"","publisher":{"@id":"https:\/\/www.rxbriefcase.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rxbriefcase.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.rxbriefcase.com\/#organization","name":"Mallette Rx","url":"https:\/\/www.rxbriefcase.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.rxbriefcase.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.rxbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","contentUrl":"https:\/\/www.rxbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","width":190,"height":36,"caption":"RxBriefCase"},"image":{"@id":"https:\/\/www.rxbriefcase.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.rxbriefcase.com\/fr\/wp-json\/wp\/v2\/product\/8183","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rxbriefcase.com\/fr\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/www.rxbriefcase.com\/fr\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rxbriefcase.com\/fr\/wp-json\/wp\/v2\/comments?post=8183"}],"wp:attachment":[{"href":"https:\/\/www.rxbriefcase.com\/fr\/wp-json\/wp\/v2\/media?parent=8183"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/www.rxbriefcase.com\/fr\/wp-json\/wp\/v2\/product_brand?post=8183"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/www.rxbriefcase.com\/fr\/wp-json\/wp\/v2\/product_cat?post=8183"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/www.rxbriefcase.com\/fr\/wp-json\/wp\/v2\/product_tag?post=8183"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}